MingCeler
明迅生物
MingCeler
Biotech/Healthcare
Mingxun Biotechnology develops animal model technologies, specializing in rapidly delivering customized genetically modified mouse models. The company claims a globally unrivaled lead time, as short as two months, and can provide homozygous mouse models.
Latest round: Pre Series A (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.